Advocacy Posts
Advocacy Update & Latest News from Cystic Fibrosis Canada: November 21
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES Trikafta to be Submitted to Health…
View Full Post
Advocacy Update & Latest News from Cystic Fibrosis Canada: November 7
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES House of Commons Standing Committee On…
View Full Post
Canadian Cystic Fibrosis Community in Crisis: Latest Developments as Wait for Life Changing Drug Continues
Today we respond not only to the Patented Medicine Prices Review Board (PMPRB) guidelines and the House of Commons Standing Committee on Health (HESA) motion,…
View Full PostAdvocacy Update & Latest News from Cystic Fibrosis Canada: October 24
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES Emergency all party meeting on access…
View Full Post
Advocacy Update & Latest News from Cystic Fibrosis Canada: October 9
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES Meeting with Minister Patty Hajdu On…
View Full PostAdvocacy Update & Latest News from Cystic Fibrosis Canada: September 25
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES Cystic fibrosis Clinicians Take a Stand…
View Full Post
Canada, what are you waiting for?
When a recent Canadian study demonstrated the dramatic life-saving benefits of the cystic fibrosis drug, Trikafta, Cystic Fibrosis Canada intensified our calls to the government…
View Full PostAdvocacy Update & Latest News from Cystic Fibrosis Canada: August 31
Please see below for the latest news and advocacy updates from Cystic Fibrosis Canada this week: #CFCantWait: ADVOCACY UPDATES 4,163 People Join Cystic Fibrosis Canada…
View Full Post
Explained: the PMPRB’s impact on access to CF medicines and what you can do to help
The Patented Medicine Prices Review Board (PMPRB) and its proposed draft guidelines have become a major concern in the Canadian cystic fibrosis (CF) community. This…
View Full Post